1390 related articles for article (PubMed ID: 33466583)
1. Therapeutic Properties of Mesenchymal Stromal/Stem Cells: The Need of Cell Priming for Cell-Free Therapies in Regenerative Medicine.
Miceli V; Bulati M; Iannolo G; Zito G; Gallo A; Conaldi PG
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466583
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning.
Ferreira JR; Teixeira GQ; Santos SG; Barbosa MA; Almeida-Porada G; Gonçalves RM
Front Immunol; 2018; 9():2837. PubMed ID: 30564236
[TBL] [Abstract][Full Text] [Related]
3. Exosomes from conditioned media of bone marrow-derived mesenchymal stem cells promote bone regeneration by enhancing angiogenesis.
Takeuchi R; Katagiri W; Endo S; Kobayashi T
PLoS One; 2019; 14(11):e0225472. PubMed ID: 31751396
[TBL] [Abstract][Full Text] [Related]
4. The secretome of mesenchymal stem cells and oxidative stress: challenges and opportunities in cell-free regenerative medicine.
Rahimi B; Panahi M; Saraygord-Afshari N; Taheri N; Bilici M; Jafari D; Alizadeh E
Mol Biol Rep; 2021 Jul; 48(7):5607-5619. PubMed ID: 34191238
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine.
Keshtkar S; Azarpira N; Ghahremani MH
Stem Cell Res Ther; 2018 Mar; 9(1):63. PubMed ID: 29523213
[TBL] [Abstract][Full Text] [Related]
6. Current status of myocardial restoration via the paracrine function of mesenchymal stromal cells.
Nguyen-Truong M; Hematti P; Wang Z
Am J Physiol Heart Circ Physiol; 2021 Jul; 321(1):H112-H127. PubMed ID: 34085844
[TBL] [Abstract][Full Text] [Related]
7. The mesenchymal stem cell secretome: A new paradigm towards cell-free therapeutic mode in regenerative medicine.
L PK; Kandoi S; Misra R; S V; K R; Verma RS
Cytokine Growth Factor Rev; 2019 Apr; 46():1-9. PubMed ID: 30954374
[TBL] [Abstract][Full Text] [Related]
8. Use of priming strategies to advance the clinical application of mesenchymal stromal/stem cell-based therapy.
Miceli V
World J Stem Cells; 2024 Jan; 16(1):7-18. PubMed ID: 38292438
[TBL] [Abstract][Full Text] [Related]
9. Dental Pulp Stem Cell-Derived Conditioned Medium: An Attractive Alternative for Regenerative Therapy.
Kichenbrand C; Velot E; Menu P; Moby V
Tissue Eng Part B Rev; 2019 Feb; 25(1):78-88. PubMed ID: 30156475
[TBL] [Abstract][Full Text] [Related]
10. Conditioned media derived from mesenchymal stem cell cultures: The next generation for regenerative medicine.
Gunawardena TNA; Rahman MT; Abdullah BJJ; Abu Kasim NH
J Tissue Eng Regen Med; 2019 Apr; 13(4):569-586. PubMed ID: 30644175
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal Stromal Cells (MSCs): A Promising Tool for Cell-Based Angiogenic Therapy.
Ulpiano C; da Silva CL; Monteiro GA
Curr Gene Ther; 2021; 21(5):382-405. PubMed ID: 34533444
[TBL] [Abstract][Full Text] [Related]
12. Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome.
Harrell CR; Fellabaum C; Jovicic N; Djonov V; Arsenijevic N; Volarevic V
Cells; 2019 May; 8(5):. PubMed ID: 31100966
[TBL] [Abstract][Full Text] [Related]
13. Revolutionizing dermatology: harnessing mesenchymal stem/stromal cells and exosomes in 3D platform for skin regeneration.
Bicer M
Arch Dermatol Res; 2024 May; 316(6):242. PubMed ID: 38795200
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cell-derived secretomes for therapeutic potential of premature infant diseases.
Wang Y; Long W; Cao Y; Li J; You L; Fan Y
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32320046
[TBL] [Abstract][Full Text] [Related]
15. Advances in mesenchymal stem cell conditioned medium-mediated periodontal tissue regeneration.
Lin H; Chen H; Zhao X; Chen Z; Zhang P; Tian Y; Wang Y; Ding T; Wang L; Shen Y
J Transl Med; 2021 Nov; 19(1):456. PubMed ID: 34736500
[TBL] [Abstract][Full Text] [Related]
16. Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming.
Redondo-Castro E; Cunningham CJ; Miller J; Brown H; Allan SM; Pinteaux E
Stem Cell Res Ther; 2018 Jan; 9(1):11. PubMed ID: 29343288
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis and functional validation reveal distinct therapeutic capabilities related to priming of mesenchymal stromal/stem cells with IFN-γ and hypoxia: potential implications for their clinical use.
Calligaris M; Zito G; Busà R; Bulati M; Iannolo G; Gallo A; Carreca AP; Cuscino N; Castelbuono S; Carcione C; Centi C; Amico G; Bertani A; Chinnici CM; Conaldi PG; Scilabra SD; Miceli V
Front Cell Dev Biol; 2024; 12():1385712. PubMed ID: 38882056
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stromal/stem cell (MSC)-derived exosomes in clinical trials.
Lotfy A; AboQuella NM; Wang H
Stem Cell Res Ther; 2023 Apr; 14(1):66. PubMed ID: 37024925
[TBL] [Abstract][Full Text] [Related]
19. The use of cell conditioned medium for musculoskeletal tissue regeneration.
Veronesi F; Borsari V; Sartori M; Orciani M; Mattioli-Belmonte M; Fini M
J Cell Physiol; 2018 Jun; 233(6):4423-4442. PubMed ID: 29159853
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal Stem Cells on Horizon: A New Arsenal of Therapeutic Agents.
Abbasi-Malati Z; Roushandeh AM; Kuwahara Y; Roudkenar MH
Stem Cell Rev Rep; 2018 Aug; 14(4):484-499. PubMed ID: 29687338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
